hydroxyurea has been researched along with 3,4,5-trihydroxybenzamidoxime in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chitambar, CR; Elford, HL; Myette, MS | 1 |
| Birch, NJ; Elford, HL; Gallicchio, VS; Greenberg, RN; Mayhew, CN; Phillips, JD | 1 |
| Smart, T | 1 |
| Ahmed, MM; Chendil, D; Elford, HL; Gallicchio, VS; Greenberg, RN; Mampuru, LJ; Mayhew, CN; Phillips, JD | 1 |
| Cibull, ML; Elford, HL; Gallicchio, VS; Mayhew, CN; Phillips, JD | 1 |
| Duvall, W; Elford, HL; Gallicchio, VS; Hagan, E; Inayat, MS; Mayhew, CN; Sumpter, LR; Yost, EE | 1 |
| Cibull, M; Elford, HL; Gallicchio, VS; Inayat, M; Mayhew, CN; Phillips, JD; Sumpter, R | 1 |
| Bhave, S; Elford, H; McVoy, MA | 1 |
9 other study(ies) available for hydroxyurea and 3,4,5-trihydroxybenzamidoxime
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Topics: Antineoplastic Agents; Benzamidines; Cell Division; Deoxycytidine; Drug Synergism; Enzyme Inhibitors; Gallium; Gemcitabine; Humans; Hydroxamic Acids; Hydroxyurea; Oximes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured | 1998 |
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Anti-HIV Agents; Benzamidines; Cells, Cultured; Colony-Forming Units Assay; Enzyme Inhibitors; Female; Femur; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hydroxamic Acids; Hydroxyurea; In Vitro Techniques; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Organ Size; Ribonucleotide Reductases; Spleen | 1999 |
Beyond hydroxyurea.
Topics: Animals; Antiviral Agents; Benzamidines; Dipyridamole; Disease Models, Animal; Floxuridine; Fluorouracil; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Murine Acquired Immunodeficiency Syndrome; Ribonucleotide Reductases | 1995 |
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
Topics: Animals; Benzamidines; Bone Marrow Cells; DNA, Viral; Female; Femur; Free Radical Scavengers; Hematopoietic Stem Cells; Hydroxamic Acids; Hydroxyurea; Hypergammaglobulinemia; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Proviruses; Retroviridae Infections; Ribonucleotide Reductases; Spleen; Splenomegaly; Tumor Virus Infections | 2002 |
Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea.
Topics: Animals; Antiviral Agents; Benzamidines; Blood Cell Count; Body Weight; Bone Marrow; Hydroxamic Acids; Hydroxyurea; Leukemia Virus, Murine; Lymphoproliferative Disorders; Mice; Spleen; Time Factors | 2002 |
In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease.
Topics: Animals; Antiviral Agents; Benzamidines; Bone Marrow Cells; Dideoxynucleosides; Disease Models, Animal; Drug Therapy, Combination; Hematopoietic Stem Cells; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Ribonucleotide Reductases; Spleen; Splenomegaly | 2004 |
Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Topics: Animals; Antiviral Agents; B-Lymphocytes; Benzamidines; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hydroxamic Acids; Hydroxyurea; Leukemia Virus, Murine; Leukemia, Experimental; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribonucleotide Reductases; Treatment Outcome; Tumor Virus Infections | 2005 |
Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Topics: Antiviral Agents; Benzamidines; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergism; Ganciclovir; Humans; Hydroxamic Acids; Hydroxyurea; Inhibitory Concentration 50; Ribonucleotide Reductases | 2013 |